Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Details Narrative)

v3.20.1
Stockholders' Equity (Details Narrative) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2019
Number of awards oustanding 1,633,612 1,639,167
Unrecognized compensation expense $ 428,000  
Compensation expense, period for recognition 1 year 9 months  
Term of warrants 5 years  
Securities Purchase Agreement (the "2019 PIPE") | Accredited Investors    
Sale of stock, number of shares issued   2,426,455
Offering costs   $ 94,000
Share price (in dollars per share)   $ 3.10
Proceeds from issuance of stock   $ 7,500,000
Amended and Restated 2013 Incentive Compensation Plan    
Common stock reserved for issuance 1,956,250  
Number of share available for grant 460,908  
Number of awards oustanding 1,080,679  
Number of awards granted 414,663